Cochrane · systematic review · CD006095

Probiotics for the prevention of Clostridium difficile‐associated diarrhea in adults and children

Goldenberg, JZ, Yap, C, Lytvyn, L, et al. · Cochrane Database of Systematic Reviews · 2017 · Cochrane Library

Gut2 versionsAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
10
current version
GRADE rated
10
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 1 · 10%Low 3 · 30%Moderate 6 · 60%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Current version only

Probiotics compared to control for preventing C. difficile associated diarrhea

Population: preventing C. difficile associated diarrhea
CD006095.PUB4 (current) · 10 questions
OutcomeEffectEvidenceStatus / GRADE
Incidence CDAD: complete case
Probiotics vs control
RR 0.4 [0.3, 0.52]31 studies · 8672 participantsModerate
Downgraded: indirectness
CDAD (baseline risk 0‐2%)
Probiotics vs control
RR 0.77 [0.45, 1.32]15 studies · 5845 participantsModerate
Downgraded: risk of bias, imprecision, inconsistency, indirectness, publication bias
CDAD (baseline risk 3‐5%)
Probiotics vs control
RR 0.53 [0.16, 1.77]3 studies · 373 participantsLow
Downgraded: risk of bias, imprecision, inconsistency, indirectness, publication bias
CDAD (baseline risk >5%)
Probiotics vs control
RR 0.3 [0.21, 0.42]13 studies · 2454 participantsModerate
Downgraded: risk of bias, imprecision, inconsistency, indirectness, publication bias
Incidence of C. difficile infection: complete case
Probiotics vs control
RR 0.86 [0.67, 1.1]15 studies · 1214 participantsModerate
Downgraded: risk of bias, imprecision, inconsistency, indirectness, publication bias
Adverse Events: complete case
Probiotics vs control
RR 0.83 [0.71, 0.97]32 studies · 8305 participantsVery low
Downgraded: risk of bias, imprecision, inconsistency, indirectness, publication bias
Incidence AAD: complete case
Probiotics vs control
RR 0.58 [0.48, 0.7]33 studies · 8870 participantsLow
Downgraded: risk of bias, imprecision, inconsistency, indirectness, publication bias
AAD (Adults)
Probiotics vs control
RR 0.62 [0.51, 0.76]23 studies · 7036 participantsLow
Downgraded: risk of bias, imprecision, inconsistency, indirectness, publication bias
AAD (Children)
Probiotics vs control
RR 0.38 [0.29, 0.49]6 studies · 1141 participantsModerate
Downgraded: risk of bias, imprecision, inconsistency, indirectness, publication bias
Length of Hospital Stay: complete case
Probiotics vs control
no estimate extracted4 studies · 3484 participantsModerate
Downgraded: risk of bias, imprecision, inconsistency, indirectness, publication bias

Probiotics for the prevention of Clostridium difficile associated diarrhea

Population: adults and children exposed to antibiotics
CD006095.PUB3 · 5 questions
OutcomeEffectEvidenceStatus / GRADE
Clostridium difficile associated diarrhea diarrhea as defined by authors + cytotoxin and culture or both
RR 0.36 [0.26, 0.51]23 studies · 4213 participantsModerate
Downgraded: risk of bias, imprecision, inconsistency, publication bias
Adverse events as defined or described by authors
RR 0.8 [0.68, 0.95]26 studies · 3964 participantsModerate
Downgraded: risk of bias, imprecision, inconsistency, publication bias
Clostridium difficile infection cytotoxin and/or culture
RR 0.89 [0.64, 1.24]13 studies · 961 participantsModerate
Downgraded: risk of bias, imprecision, publication bias
Length of hospital stay days spent in hospital
no estimate extracted3 studies · 422 participantsLow
Downgraded: risk of bias, imprecision, inconsistency, publication bias
Antibiotic associated diarrhea as defined by study authors
RR 0.6 [0.49, 0.72]25 studies · 4097 participantsLow
Downgraded: risk of bias, imprecision, inconsistency, publication bias